Alligator Bioscience Successfully Completes End of Phase 2 Interaction with FDA For Mitazalimab
LUND, SE / ACCESS Newswire / February 6, 2025 / Alligator Bioscience (STO:ATORX) FDA feedback validates the clinical ...
Swedish digital asset manager launches Avalanche, Cardano ETP on Nasdaq Helsinki
Swedish crypto asset manager Virtune has introduced new crypto exchange-traded products (ETPs) for investors in Finland, ...
NAMIBIA OPERATIONAL UPDATE
Africa Oil Corp. ("Africa Oil", or the "Company") notes the announcement by its investee company, Impact Oil & Gas Limited ...
Sampo announces share split, expands total shares
HELSINKI - Sampo plc's Board of Directors has announced a share split, issuing new shares to its shareholders without any ...
LUCARA RECEIVED FINAL APPROVAL TO CHANGE ITS SWEDISH LISTING TO NASDAQ FIRST NORTH GROWTH MARKET
Lucara Diamond Corp. ("Lucara" or the "Company") is pleased to announce that it has met all conditions relating to the ...
Irish Independent on MSN1d
Kingspan poised to take over Swedish company in deal worth almost €49m
The board of Nordic Waterproofing has unanimously recommended that shareholders accept a takeover offer from Kingspan, the Irish insulation giant. The Cavan-based firm, whose CEO is Gene Murtagh, is ...
Hansa Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results
Hansa Biopharma AB, Hansa or the Company (Nasdaq Stockholm: HNSA) today announced its full year and Q4 2024 financial results.
LUCARA WILL CHANGE ITS SWEDISH LISTING TO NASDAQ FIRST NORTH GROWTH MARKET
VANCOUVER, B.C., Jan. 24, 2025 /CNW/ - (LUC – TSX, LUC – BSE, LUC – Nasdaq Stockholm) ...
Hansa Biopharma AB: Hansa Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results
IDEFIRIX Product Sales Increased 83% Compared to the Prior Year LUND, Sweden, Feb. 6, 2025 /PRNewswire/ -- Hansa Biopharma AB, Hansa or the Company (Nasdaq Stockholm: HNSA) today announced ...